Axsome Therapeutics, Inc. (AXSM)
NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
As of 11:00AM EDT. Market open.
| Previous close | 71.10 |
| Open | 71.53 |
| Bid | 72.76 x 200 |
| Ask | 91.59 x 200 |
| Day's range | 70.30 - 74.25 |
| 52-week range | 55.02 - 98.40 |
| Volume | |
| Avg. volume | 732,850 |
| Market cap | 3.453B |
| Beta (5Y monthly) | 1.10 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Insider Monkey
15 Most Black States in the US
In this article, we will be taking a look at the 15 most black states in the US. If you do not want to learn about the demographics of global black population, head straight to the 5 Most Black States in the US. Overview of the Global Black Population: Demographics, Trends, and Immigration Patterns The […]
- Zacks
Axsome (AXSM) Begins Solriamfetol Binge Eating Phase III Study
Axsome's (AXSM) phase III ENGAGE study is set to evaluate the efficacy and safety of solriamfetol for the treatment of binge eating disorder in adults.
- GuruFocus.com
Insider Sell: COO Mark Jacobson Sells 24,662 Shares of Axsome Therapeutics Inc (AXSM)
Axsome Therapeutics Inc (NASDAQ:AXSM), a biopharmaceutical company focused on developing novel therapies for the management of central nervous system (CNS) disorders, has reported an insider sell according to a recent SEC filing.
© 2024 Yahoo. All rights reserved.